A new emergency treatment for allergic reactions will now be available in the UK – in the form of a nasal spray. The first needle-free emergency treatment for anaphylaxis – in the form of a nasal ...

The rate of hospital admissions in the United Kingdom for food-induced anaphylaxis more than tripled over the 20 years from 1998 to 2018, but the case fatality rate fell by more than half, researchers ...

An adrenaline nasal spray for the emergency treatment of anaphylaxis has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA). This marks the first time a needle-free ...

Groups have called for a system that monitors fatal allergic reactions in the United Kingdom to receive continued support. The British Society for Allergy & Clinical Immunology (BSACI) is leading the ...

LONDON, Dec 9 (Reuters) - Britain's medicine regulator said anyone with a history of anaphylaxis to a medicine or food should not get the Pfizer-BioNTech COVID-19 vaccine, giving fuller guidance on an ...

LONDON, Dec 10 (Reuters) - The UK's medicine regulator said anyone with a history of anaphylaxis to a medicine or food should not get the Pfizer-BioNTech COVID-19 vaccine, giving fuller guidance on an ...

Please provide your email address to receive an email when new articles are posted on . Although current guidelines recommend calls to emergency medical services and ED visits in response to ...

Please provide your email address to receive an email when new articles are posted on . The study included 702,917 CT scans performed for 298,328 patients. There were 2.7 cases of life-threatening ...

Anaphylaxis can cause severe itching, difficulty breathing, fainting, and abdominal pain. These symptoms usually begin about 30 minutes after coming into contact with an allergy trigger. First, call ...

All Greencore sites took part in a range of fun and meaningful activities, including a vibrant ‘Wear it Bright’ themed day, fancy dress, quizzes, and competitions — all designed to spark conversations ...

Three G protein–coupled receptors, the cysteinyl leukotriene receptors 1, 2, and 3 (CysLTR1, CysLTR2, and CysLTR3), mediate the effects of the cysteinyl leukotrienes in vivo. (Each receptor has a ...